Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Expert Financial Analysis and Reporting

Cryoport: Stock Has Been Attacked by Short Sellers (CYRX, $14.57, Buy)

Opinion on Stock

The recent sharp price decline has not been attributable to any change in perceived or actual fundamentals of…
Read more…

Part 10 of Illegal Naked Shorting Series:  Legal Shorting of Stocks is a Loser’s Game but Illegal Naked Shorting Transforms It into a Winner’s Game

Upfront Caveat

When I launched my research on stock manipulation and the prominent role played by illegal naked shorting, I believed…
Read more…

Part 9 of Illegal Naked Shorting Series:  The Risk/ Reward of Shorting Versus Buying Stocks is Extremely Unfavorable

Investment Overview

Selling something you don’t own seems a pretty alien concept to me. I struggle to find any business models…
Read more…

Part 8: Illegal Naked Shorting Series: Who or What is Cede and What Role Does Cede Play in the Trading of Stocks?

You Really Don’t Own the Shares that Appear in Your Brokerage Account; They Belong to Cede

Most investors when they buy…
Read more…

Part 7: Illegal Naked Shorting: DTCC Continuous Net Settlement and Stock Borrowing Programs Have Loopholes That Facilitate Illegal Naked Shorting

Acronyms Used Frequently in This Report

DTCC: The Depository Trust & Clearing Corporation (DTCC) provides clearing and settlement services to the…
Read more…

Part 6 Illegal Naked Shorting: The SEC’s Regulation SHO is Intended to Prevent Illegal Naked Shorting, But is Ineffective

Overview

In previous blogs I traced the history of stock trading from the 1960s when stock certificates and cash were physically…
Read more…

Part 5 in Series on Illegal Naked Shorting’s Role in Stock Manipulation: Traditional Shorting Compared to Naked Shorting (Both Legal and Illegal)

Introduction

 This is the fifth blog in the series that I am writing to describe how illegal naked shorting is used…
Read more…

Part 4 in Series on Illegal Naked Shorting’s Role in Stock Manipulation: Who are the Key Players?

Introduction

I worked on Wall Street as an analyst for nearly 40 years and was involved in the stock market on…
Read more…

Northwest Biotherapeutics: Right to Try Law Potentially Could Lead to Meaningful Revenues Prior to Formal Approval of DCVax-L (NWBO, Buy, $0.30)

Investment Perspective

Last week, a manuscript was published in a peer reviewed journal that dealt with blinded results of the phase…
Read more…

Northwest Biotherapeutics: 8-K Document Released Today Provides New and Very Interesting Data on Patients Treated with DCVax-L. (NWBO, Buy, $0.48)

Substance of 8-K Regulatory Document

Northwest issued an 8-K today in response to shareholders’ questions about an issue that has been…
Read more…

Illegal Naked Short Selling Appears to Lie at the Heart of an Extensive Stock Manipulation Scheme

Investment Consequences of Naked Shorting

Only a motivated enforcement agency with subpoena power and an accompanying powerful enforcement infrastructure can prove…
Read more…